Apparent inactivation of alpha 1-antiproteinase by sulphur-containing radicals derived from penicillamine.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Biochemical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 2557847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ESR investigations of the reactions of radiation-produced thiyl and DNA peroxyl radicals: formation of sulfoxyl radicals.

  1989cited by this paper
• Antitrypsin and emphysema. Perspective and prospects.

  1988cited by this paper
• The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs.

  1988cited by this paper
• The deoxyribose assay: an assay both for 'free' hydroxyl radical and for site-specific hydroxyl radical production.

  1988cited by this paper
• Inactivation of alpha‐1‐proteinase inhibitor in serum by stimulated human polymorphonuclear leucocytes. Evidence for a myeloperoxidase‐dependent mechanism

  1988cited by this paper
• Aromatic hydroxylation of phenylalanine as an assay for hydroxyl radicals: application to activated human neutrophils and to the heme protein leghemoglobin.

  1988cited by this paper
• Oxidants, inflammation, and anti‐inflammatory drugs

  1988cited by this paper
• On the reaction of molecular oxygen with thiyl radicals: a re-examination.

  1987cited by this paper
• Biologically-significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by some anti-inflammatory drugs.

  1987cited by this paper
• The antioxidant action of human extracellular fluids. Effect of human serum and its protein components on the inactivation of alpha 1-antiproteinase by hypochlorous acid and by hydrogen peroxide.

  1987cited by this paper
• The deoxyribose method: a simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals.

  1987cited by this paper
• Interactions of thiyl free radicals with oxygen: a pulse radiolysis study.

  1986cited by this paper
• Collagenolytic metalloenzymes of the human neutrophil. Characteristics, regulation and potential function in vivo.

  1986cited by this paper
• Stimulated human neutrophils limit iron-catalyzed hydroxyl radical formation as detected by spin-trapping techniques.

  1986cited by this paper
• The importance of free radicals and catalytic metal ions in human diseases.

  1985cited by this paper
• Mechanisms of cigarette smoke toxicity: the inactivation of human alpha-1-proteinase inhibitor by nitric oxide/isoprene mixtures in air.

  1985cited by this paper
• Reactivity of hydroxyl and hydroxyl-like radicals discriminated by release of thiobarbituric acid-reactive material from deoxy sugars, nucleosides and benzoate.

  1984cited by this paper
• Human plasma proteinase inhibitors.

  1983cited by this paper
• Antiinflammatory drugs: protection of a bacterial virus as an in vitro biological measure of free radical activity.

  1983cited by this paper
• Structure and variation of human α1–antitrypsin

  1982cited by this paper
• Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils.

  1981cited by this paper
• Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.

  1980cited by this paper
• In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.

  1979cited by this paper

• Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy

  2022cites this paper
• Mechanisms of diabetic neuropathy: axon dysfunction.

  2014cites this paper
• Applications d'une modulation pharmacologique des dérives des formes réactives de l'oxygène pour une optimisation thérapeutique des patients traités par chimiothérapie

  2012cites this paper
• Diabetic neuropathy and oxidative stress

  2006cites this paper
• Inhibition of protein hydroperoxide formation by protein thiols

  2003cites this paper
• In vitro effects of NSAIDS and paracetamol on oxidative stress-related parameters of human erythrocytes.

  2001cites this paper
• The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society

  2001cites this paper
• Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes.

  2000cites this paper
• The in vitro effects of new non-steroidal antiinflammatory compounds on antioxidant system of human erythrocytes.

  1999cites this paper
• Modulation of peroxynitrite‐ and hypochlorous acid‐induced inactivation of α1‐antiproteinase by mercaptoethylguanidine

  1999cites this paper
• The role of N-acetylcysteine in protecting synovial fluid biomolecules against radiolytically-mediated oxidative damage: a high field proton NMR study.

  1999cites this paper
• Thiols and disulphides can aggravate peroxynitrite‐dependent inactivation of α1‐antiproteinase

  1997cites this paper
• Hydroxyl radical scavenging activity of nonsteroidal anti-inflammatory drugs.

  1997cites this paper
• Anti-oxidant therapy: does it have a role in the treatment of human disease?

  1997cites this paper
• Characterization of drugs as antioxidant prophylactics.

  1996cites this paper
• D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.

  1996cites this paper
• Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid.

  1996cites this paper
• The characterization of antioxidants.

  1995cites this paper
• Side-effects of drugs used in the treatment of rheumatoid arthritis.

  1995cites this paper
• Evaluation of the antioxidant properties of the angiotensin-converting enzyme inhibitor, captopril and the nucleotide enhancing agent, acadesine.

  1995cites this paper
• How to characterize an antioxidant: an update.

  1995cites this paper
• Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation.

  1994cites this paper
• Promotion of oxidative damage to arachidonic acid and alpha 1-antiproteinase by anti-inflammatory drugs in the presence of the haem proteins myoglobin and cytochrome C.

  1994cites this paper
• Determination of non-protein-bound iron in human synovial fluid by high-performance liquid chromatography with electrochemical detection.

  1994cites this paper
• Cigarette smoking, emphysema, and damage to alpha 1-proteinase inhibitor.

  1994cites this paper
• The Chemistry of Free Radicals

  1993cites this paper
• Drug derived radicals: mediators of the side effects of anti-inflammatory drugs?

  1992cites this paper
• Free radicals, antioxidants, and human disease: where are we now?

  1992cites this paper
• Oxidative damage to lipids and alpha 1-antiproteinase by phenylbutazone in the presence of haem proteins: protection by ascorbic acid.

  1992cites this paper
• Reactive oxygen species in living systems: source, biochemistry, and role in human disease.

  1991cites this paper
• Effect of additives on the inactivation of lysozyme mediated by free radicals produced in the thermolysis of 2,2'-azo-bis-(2-amidinopropane).

  1991cites this paper
• Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species.

  1991cites this paper
• Drug Antioxidant Effects

  1991cites this paper
• Leukocyte-mediated inactivation of alpha 1-proteinase inhibitor is inhibited by amino analogues of alpha-tocopherol.

  1991cites this paper
• Free radical scavengers and inflammatory bowel disease.

  1991cites this paper
• Scavenging of hypochlorous acid and of myoglobin-derived oxidants by the cardioprotective agent mercaptopropionylglycine.

  1990cites this paper
• Control of oxidative damage in rheumatoid arthritis by gold(I)-thiolate drugs.

  1990cites this paper
• How to characterize a biological antioxidant.

  1990cites this paper